Gilead Sciences Financial Health

How is Gilead Sciences's financial position?

Financial Health Score

3/6

Financial Health Score 3/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Debt Coverage

  • Interest Coverage

Financial Position Analysis

Short Term Liabilities: GILD's short term assets ($13.6B) exceed its short term liabilities ($10.4B).

Long Term Liabilities: GILD's short term assets ($13.6B) do not cover its long term liabilities ($31.1B).


Debt to Equity History and Analysis

Debt Level: GILD's net debt to equity ratio (90.2%) is considered high.

Reducing Debt: GILD's debt to equity ratio has increased from 116.3% to 119.8% over the past 5 years.

Debt Coverage: GILD's debt is well covered by operating cash flow (38.5%).

Interest Coverage: GILD's interest payments on its debt are well covered by EBIT (11.3x coverage).


Balance Sheet


Discover healthy companies